- The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy
-
Kapoor S
- KMID: 1776463
- Korean J Intern Med.
- 2013 May;28(3):374-376.
- doi: 10.3904/kjim.2013.28.3.374
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Stereological Comparison of the Effects of Pentoxifylline, Captopril, Simvastatin, and Tamoxifen on Kidney and Bladder Structure After Partial Urethral Obstruction in Rats
-
Shirazi M, Soltani MR, Jahanabadi Z, Abdollahifar MA, Tanideh N, Noorafshan A
- KMID: 2069919
- Korean J Urol.
- 2014 Nov;55(11):756-763.
- doi: 10.4111/kju.2014.55.11.756
PURPOSE: Limited studies have shown antifibrotic effects of pentoxifylline, captopril, simvastatin, and tamoxifen. No comparisons are available of the effects of these drugs on prevention of renal and bladder changes... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Phosphodiesterase Inhibitor on Diabetic Nephropathy
-
Kang SW
- KMID: 1776540
- Korean J Intern Med.
- 2012 Jun;27(2):151-153.
- doi: 10.3904/kjim.2012.27.2.151
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Phosphodiesterase Inhibitor Improves Renal Tubulointerstitial Hypoxia of the Diabetic Rat Kidney
-
Sun HK, Lee YM, Han KH, Kim HS, Ahn SH, Han SY
- KMID: 1776543
- Korean J Intern Med.
- 2012 Jun;27(2):163-170.
- doi: 10.3904/kjim.2012.27.2.163
BACKGROUND/AIMS: Renal hypoxia is involved in the pathogenesis of diabetic nephropathy. Pentoxifyllin (PTX), a nonselective phosphodiesterase inhibitor, is used to attenuate peripheral vascular diseases. To determine whether PTX can improve... -
- CITED
-
- Close
- SHARE
-
- Close
